<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum News</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Meet the “Mitochondrial Plaque,” a New Alzheimer’s Pathology?</title>
 <link>https://www.alzforum.org/news/research-news/meet-mitochondrial-plaque-new-alzheimers-pathology</link>
 <description>In amyloid mice and postmortem human AD brain, mitochondria-packed dystrophic neurites appear to cluster into large, “plaque-like” structures.</description>
 <pubDate>26 Aug 2026 12:21:39 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/meet-mitochondrial-plaque-new-alzheimers-pathology#comments</comments>
</item>
<item>
 <title>Splicing Modulator Stops 4R Tau at the Source, Lowers Pathology</title>
 <link>https://www.alzforum.org/news/research-news/splicing-modulator-stops-4r-tau-source-lowers-pathology</link>
 <description>In transgenic mice and human neurons, the compound lowered aggregation-prone 4R tau, p-tau, insoluble tau. It needs further tweaking for stability and selectivity.</description>
 <pubDate>21 Aug 2026 15:45:36 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/splicing-modulator-stops-4r-tau-source-lowers-pathology#comments</comments>
</item>
<item>
 <title>Therapeutic Twofer Supplies Progranulin That Evades Sortilin</title>
 <link>https://www.alzforum.org/news/research-news/therapeutic-twofer-supplies-progranulin-evades-sortilin</link>
 <description>In mice, viral delivery of this modified protein outperformed conventional progranulin on multiple fronts.</description>
 <pubDate>21 Aug 2026 14:17:50 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/therapeutic-twofer-supplies-progranulin-evades-sortilin#comments</comments>
</item>
<item>
 <title>How Specialized Macrophages Defend the Brain’s Borders</title>
 <link>https://www.alzforum.org/news/research-news/how-specialized-macrophages-defend-brains-borders</link>
 <description>The transcription factor c-MAF programs specialized border-associated macrophages to maintain a healthy cerebrovasculature and protect against Alzheimer’s. Not so in ApoE4 carriers.</description>
 <pubDate>20 Aug 2026 10:25:47 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/how-specialized-macrophages-defend-brains-borders#comments</comments>
</item>
<item>
 <title>Senescent Microglia Release Protein That Disrupts Myelin, Riles Neurons</title>
 <link>https://www.alzforum.org/news/research-news/senescent-microglia-release-protein-disrupts-myelin-riles-neurons</link>
 <description>The newly identified senescence factor, sDLK1, binds Notch, hampers oligodendrocyte maturation, and perturbs neuronal calcium signaling. It rises with age.</description>
 <pubDate>19 Aug 2026 15:18:06 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/senescent-microglia-release-protein-disrupts-myelin-riles-neurons#comments</comments>
</item>
<item>
 <title>Is Early Menopause a Warning Sign for Alzheimer’s?</title>
 <link>https://www.alzforum.org/news/conference-coverage/early-menopause-warning-sign-alzheimers</link>
 <description>Molecular changes unfolding during menopause might render the brain more vulnerable to dementia in some women. Topping the list: inflammation and synaptic dysfunction.</description>
 <pubDate>18 Aug 2026 09:33:35 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/early-menopause-warning-sign-alzheimers#comments</comments>
</item>
<item>
 <title>Phospho-Tau Infiltrates Mitochondria, Reverses Electron Flow </title>
 <link>https://www.alzforum.org/news/research-news/phospho-tau-infiltrates-mitochondria-reverses-electron-flow</link>
 <description>In tauopathy mice, reverse electron transport runs rampant. Blocking it curbs neurodegeneration.</description>
 <pubDate>14 Aug 2026 17:14:19 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/phospho-tau-infiltrates-mitochondria-reverses-electron-flow#comments</comments>
</item>
<item>
 <title>Might AI Help Sharpen Dementia Diagnosis? </title>
 <link>https://www.alzforum.org/news/conference-coverage/might-ai-help-sharpen-dementia-diagnosis</link>
 <description>Researchers unveil an AI model designed to use medical records to predict the underlying neuropathology driving a person’s cognitive dysfunction.</description>
 <pubDate>13 Aug 2026 01:16:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/might-ai-help-sharpen-dementia-diagnosis#comments</comments>
</item>
<item>
 <title>Do Younger People Clear Plaque Slowly Because They Have More Tangles?</title>
 <link>https://www.alzforum.org/news/conference-coverage/do-younger-people-clear-plaque-slowly-because-they-have-more-tangles</link>
 <description>The age effect may actually be a tau effect as tangles hamper antibody efficacy; new data add evidence that lecanemab slows tau buildup.  </description>
 <pubDate>12 Aug 2026 15:49:04 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/do-younger-people-clear-plaque-slowly-because-they-have-more-tangles#comments</comments>
</item>
<item>
 <title>Better Never Than LATE: TDP-43 Pathology in Alzheimer&#039;s Disease </title>
 <link>https://www.alzforum.org/news/conference-coverage/better-never-late-tdp-43-pathology-alzheimers-disease</link>
 <description>TDP-43 co-pathology means other proteins are more likely to aggregate in Alzheimer&#039;s disease. </description>
 <pubDate>12 Aug 2026 12:56:05 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/better-never-late-tdp-43-pathology-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Two Diseases, One Microglial Response … to Lame Lysosomes</title>
 <link>https://www.alzforum.org/news/research-news/two-diseases-one-microglial-response-lame-lysosomes</link>
 <description>In neurodegenerative diseases driven by lysosomal dysfunction, microglia initiate a transcriptional program that first helps, then hinders.</description>
 <pubDate>11 Aug 2026 13:18:23 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/two-diseases-one-microglial-response-lame-lysosomes#comments</comments>
</item>
<item>
 <title>Healthy Arteries, Slow Titration Mean Less ARIA</title>
 <link>https://www.alzforum.org/news/conference-coverage/healthy-arteries-slow-titration-mean-less-aria</link>
 <description>Scientists linked APOE2 and diastolic blood pressure to ARIA-E. More slowly upping antibody dose lessens the risk. Better patient screening lowers ARIA-H.  </description>
 <pubDate>07 Aug 2026 15:05:40 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/healthy-arteries-slow-titration-mean-less-aria#comments</comments>
</item>
<item>
 <title>Bespoke Shuttles: Scientists Tailor Transporters for Therapeutic Targets</title>
 <link>https://www.alzforum.org/news/conference-coverage/bespoke-shuttles-scientists-tailor-transporters-therapeutic-targets</link>
 <description>Oligonucleotide-based therapies are increasingly being fitted with shuttle constructs. Is TfR always the best choice?</description>
 <pubDate>05 Aug 2026 13:26:05 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/bespoke-shuttles-scientists-tailor-transporters-therapeutic-targets#comments</comments>
</item>
<item>
 <title>Brain Shuttles: A Coming Boom?</title>
 <link>https://www.alzforum.org/news/conference-coverage/brain-shuttles-coming-boom</link>
 <description>Extending well beyond anti-Aβ antibodies, development of brain-shuttled therapies for AD has become highly competitive. </description>
 <pubDate>05 Aug 2026 13:24:14 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/brain-shuttles-coming-boom#comments</comments>
</item>
<item>
 <title>Is a Blood Test for Cerebrovascular Disease on the Horizon?</title>
 <link>https://www.alzforum.org/news/conference-coverage/blood-test-cerebrovascular-disease-horizon</link>
 <description>Disease in the brain’s vasculature raises a person’s risk of dementia, but there is no easy way to measure it. At AAIC, scientists reported blood marker panels that might.</description>
 <pubDate>04 Aug 2026 16:22:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/blood-test-cerebrovascular-disease-horizon#comments</comments>
</item>
<item>
 <title>Proteomic Meta Analysis Paints Landscape of Neurological Markers</title>
 <link>https://www.alzforum.org/news/conference-coverage/proteomic-meta-analysis-paints-landscape-neurological-markers</link>
 <description>The concentrations of 42 proteins in CSF show different patterns in 41 neurological disorders.</description>
 <pubDate>04 Aug 2026 14:54:48 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/proteomic-meta-analysis-paints-landscape-neurological-markers#comments</comments>
</item>
<item>
 <title>Cognitively Sharp Centenarians Sidestep Tau Pathology</title>
 <link>https://www.alzforum.org/news/conference-coverage/cognitively-sharp-centenarians-sidestep-tau-pathology</link>
 <description>Despite an amyloid burden on par with Alzheimer&#039;s disease, many centenarians keep tau tangles at bay.</description>
 <pubDate>04 Aug 2026 10:17:04 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/cognitively-sharp-centenarians-sidestep-tau-pathology#comments</comments>
</item>
<item>
 <title>As Immunotherapy Use Grows, U.S. Clinics Innovate to Handle the Load</title>
 <link>https://www.alzforum.org/news/conference-coverage/immunotherapy-use-grows-us-clinics-innovate-handle-load</link>
 <description>Greater reliance on trained nurses and primary care, as well as the availability of subcutaneous lecanemab, may help accommodate growing caseloads.</description>
 <pubDate>31 Jul 2026 17:38:42 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/immunotherapy-use-grows-us-clinics-innovate-handle-load#comments</comments>
</item>
<item>
 <title>In China and U.S. Real-World Use, Leqembi Seems to Stabilize Cognition</title>
 <link>https://www.alzforum.org/news/conference-coverage/china-and-us-real-world-use-leqembi-seems-stabilize-cognition</link>
 <description>As cohorts expand, with a few people reaching three years on drug, accumulating data suggests their Alzheimer’s disease has slowed.</description>
 <pubDate>31 Jul 2026 16:12:26 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/china-and-us-real-world-use-leqembi-seems-stabilize-cognition#comments</comments>
</item>
<item>
 <title>De-Risking Donanemab: Dosing Tweak Cuts ARIA; Steroids, Not so Much</title>
 <link>https://www.alzforum.org/news/conference-coverage/de-risking-donanemab-dosing-tweak-cuts-aria-steroids-not-so-much</link>
 <description>As cohorts expand, with a few people reaching three years on drug, accumulating data suggests their Alzheimer’s disease has slowed.</description>
 <pubDate>31 Jul 2026 13:10:21 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/de-risking-donanemab-dosing-tweak-cuts-aria-steroids-not-so-much#comments</comments>
</item>
<item>
 <title>Plasma P-Tau217 Test Improves Diagnosis, Clinician Confidence </title>
 <link>https://www.alzforum.org/news/conference-coverage/plasma-p-tau217-test-improves-diagnosis-clinician-confidence</link>
 <description>In primary and secondary care in Sweden, the blood test led to changes in diagnosis and disease management. </description>
 <pubDate>30 Jul 2026 18:03:50 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/plasma-p-tau217-test-improves-diagnosis-clinician-confidence#comments</comments>
</item>
<item>
 <title>Scientists Chart Tau Modifications as Alzheimer’s Advances</title>
 <link>https://www.alzforum.org/news/conference-coverage/scientists-chart-tau-modifications-alzheimers-advances</link>
 <description>At AAIC, scientists map the myriad of post-translational modifications tau accrues through pathology stages. One goal: new biomarkers.</description>
 <pubDate>28 Jul 2026 15:43:59 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/scientists-chart-tau-modifications-alzheimers-advances#comments</comments>
</item>
<item>
 <title>Can P-Tau217 Predict Alzheimer’s Symptoms in Healthy People?</title>
 <link>https://www.alzforum.org/news/conference-coverage/can-p-tau217-predict-alzheimers-symptoms-healthy-people</link>
 <description>Data shown at AAIC suggests that the plasma marker helps determine whose cognition will decline within two to 10 years. But no slam dunk.</description>
 <pubDate>28 Jul 2026 13:27:58 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/can-p-tau217-predict-alzheimers-symptoms-healthy-people#comments</comments>
</item>
<item>
 <title>PrevenTRON and Beyond</title>
 <link>https://www.alzforum.org/news/conference-coverage/preventron-and-beyond</link>
 <description>A secondary prevention trial evaluating trontinemab’s ability to keep symptoms at bay in people with brain amyloid deposition will start later this year.  </description>
 <pubDate>24 Jul 2026 17:24:29 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/preventron-and-beyond#comments</comments>
</item>
<item>
 <title>In Open-Label Extension, Trontinemab Keeps Amyloid at Bay</title>
 <link>https://www.alzforum.org/news/conference-coverage/open-label-extension-trontinemab-keeps-amyloid-bay</link>
 <description>In Phase 2 OLE, brain amyloid dropped further below threshold of positivity, plasma kept going down GFAP. Phase 3 trials are enrolling. </description>
 <pubDate>24 Jul 2026 17:01:08 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/open-label-extension-trontinemab-keeps-amyloid-bay#comments</comments>
</item>
<item>
 <title>TSPO in FTD: A Marker of Microglia Munching Myelin?</title>
 <link>https://www.alzforum.org/news/conference-coverage/tspo-ftd-marker-microglia-munching-myelin</link>
 <description>At AAIC, researchers report that TSPO-PET signals in frontotemporal dementia come from phagocytic microglia amassing in white matter. </description>
 <pubDate>24 Jul 2026 14:03:47 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/tspo-ftd-marker-microglia-munching-myelin#comments</comments>
</item>
<item>
 <title>C-BRAIN Releases Its First Four AI Tools to Alzheimer’s Scientists </title>
 <link>https://www.alzforum.org/news/conference-coverage/c-brain-releases-its-first-four-ai-tools-alzheimers-scientists</link>
 <description>The open-source tools are still in development. C-BRAIN has opened them to the scientific community to try them and offer feedback. </description>
 <pubDate>24 Jul 2026 12:33:41 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/c-brain-releases-its-first-four-ai-tools-alzheimers-scientists#comments</comments>
</item>
<item>
 <title>Longitudinal PET Scans Reveal Amyloid Immunotherapy Use</title>
 <link>https://www.alzforum.org/news/conference-coverage/longitudinal-pet-scans-reveal-amyloid-immunotherapy-use</link>
 <description>In an observational study, marked drops in brain amyloid flagged people who, unbeknownst to investigators, had started anti-amyloid therapy.</description>
 <pubDate>22 Jul 2026 18:53:50 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/longitudinal-pet-scans-reveal-amyloid-immunotherapy-use#comments</comments>
</item>
<item>
 <title>Tau ASO Phase 2 Data Draw Crowd, Mixed Reactions</title>
 <link>https://www.alzforum.org/news/conference-coverage/tau-aso-phase-2-data-draw-crowd-mixed-reactions</link>
 <description>At AAIC, Biogen presented diranersen data. Despite missing its endpoint, the drug showed enough target engagement and cognitive benefit to go to Phase 3.</description>
 <pubDate>22 Jul 2026 18:47:06 EDT</pubDate>
 <comments>https://www.alzforum.org/news/conference-coverage/tau-aso-phase-2-data-draw-crowd-mixed-reactions#comments</comments>
</item>
<item>
 <title>Two New Ways to Attack TDP-43</title>
 <link>https://www.alzforum.org/news/research-news/two-new-ways-attack-tdp-43</link>
 <description>A molecule that binds TDP-43 extends survival in ALS mice. Interrupting steric zippers stops aggregation of a short TDP-43 isoform; alters RNA splicing.</description>
 <pubDate>18 Jul 2026 19:54:47 EDT</pubDate>
 <comments>https://www.alzforum.org/news/research-news/two-new-ways-attack-tdp-43#comments</comments>
</item>
</channel>
</rss>
